Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca2+-NFATc1 and Cav-1 signaling pathways
Binhua Zou(Southern Medical University), Xiaojuan Li(Guilin Medical University), Ligang Jie(Zhujiang Hospital), Minhong Ke(Southern Medical University), Wende Deng(Southern Medical University), Zongbao Ding(Southern Medical University), Yan Chen(Sun Yat-sen University), Qinghong Yu(Zhujiang Hospital), Yuan Qu(Zhujiang Hospital), Yanhui Tan(Southern Medical University), Jiehuang Zheng(Guangdong Pharmaceutical University), Qin Yang(Zhujiang Hospital)
Cited by 46
Related Papers
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota
|Journal of the American Chemical Society|2023|177
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
|Acta Pharmaceutica Sinica B|2021|158
Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer
|Nano Research|2020|145
Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway
|Acta Pharmacologica Sinica|2019|120
Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
|Chinese Chemical Letters|2020|97